Many Australians may not realise that pharmaceutical products — including packaged medicines, wound care items, and blood products — are among Australia’s top exports to the United States. In 2024, these exports reached around US$1.35 billion. So what’s the issue here? It’s not just about trade volumes — it’s about how patents and regulatory systems impact market access, costs, and competition.